Ratings by Clear Street
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 8/31/2026 | Kaveri Pohlman | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
173.00 (N/A) |
|
Details | |
| 8/21/2026 | Greg Pendy | Anterix Inc. | ATEX | Maintain | Buy (N/A) |
161.00 (N/A) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 229 more... | |||||||||
